APTO - Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday March 26 2024 | Benzinga
SAN DIEGO and TORONTO, March 18, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO, TSX:APS), a clinical- stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, will report financial results for the fourth quarter and year ended December 31, 2023, on Tuesday, March 26, 2024, after the close of the market, and provide a corporate update.
| Conference Call & Webcast: |
| Date: |
| Tuesday, March 26, 2024 |
| Time: |
| 5:00 PM ET |
| Audio Webcast Only: |
| link |
| Q&A Participant Registration Link*: |
| link |
| (https://register.vevent.com/register/BIe69f08fc83634a6aa38bf7081d82c6a2) |
*Analysts interested in participating in the question-and-answer session will pre-register for the event from the participant registration ...